Abstract:Background Aseptic loosening around the prosthesis is a common cause of failure in total joint arthroplasty. Periprosthetic osteolysis, which is usually caused by polyethylene wear particles, triggers the release of inflammatory factors by macrophages. Key mediators involved in osteoclastogenesis include interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), receptor activator of NF-kB (RANK), RANK ligand (RANKL), and bone protection hormone (OPG). The purpose of our experiment was to see whether melittin can slow down the release of inflammatory mediators through the NF-kB pathway, regulate the RANKL/OPG ratio, reduce osteoclast formation, and delay the onset of arthritis in rats. Methods A total of 20 male Sprague-Dawley rats (10 months, Specific Pathogen Free (SPF), 350 g ± 20 g) were randomly divided into five groups: sham group, model group, melittin concentration 1 group (0.2 mg/kg), concentration 2 group (0.4 mg/kg), and concentration 3 group (0.6 mg/kg). All rats were implanted with TA2 high-purity titanium rods. A drill was used to create a bone canal along the long axis of the femur in the intercondylar notch. The model group and experimental groups were exposed to polyethylene particles (PE), while the sham group did not receive any particles. Results The melittin group exhibited significantly increased serum levels of serum P, calcium-phosphorus product, OPG, PINP, PINP/CTX-I, and OPG/RANKKL (P < 0.05). In the experimental group, Micro-CT (Micro Computed Tomography) scanning results revealed a decrease in the amount of bone defect around the prosthesis. Immunofluorescence analysis demonstrated a decrease in the expression of IKKα and P65, while the expression of OPG showed an upward trend. Both HE (Hematoxylin-Eosin) and TRAP (Tartrate-Resistant Acid Phosphatase) staining revealed less osteoclast and inflammatory cell infiltration in bone resorption pits. Conclusion Our study demonstrates that melittin has the ability to inhibit the NF-kB pathway in a rat model, attenuate the inflammatory response associated with periprosthetic osteolysis, and reduce the impact of RANKL/OPG, thereby delaying osteoclast activity and alleviating periprosthetic osteolysis.

11R-VIVIT Peptide Inhibits Calvaria Osteolysis Induced by Experimental Design.

[The Study on the Inhibitive Effects of Recombinant Parathyroid Hormone (1-34) on Osteolysis in a Murine Calvarial Model Induced by Wear Particles].

Platelet-Derived Growth Factor-Bb Attenuates Titanium-Particle-Induced Osteolysis in Vivo

Intermittent Administration of Parathyroid Hormone [1-34] Prevents Particle-Induced Periprosthetic Osteolysis in a Rat Model.

Peptide 11R-VIVIT Promotes Fracture Healing in Osteoporotic Rats

Effects of Sequential Treatment with Intermittent Parathyroid Hormone and Zoledronic Acid on Particle-Induced Implant Loosening: Evidence from a Rat Model

Blockade of Calcium Phosphatase (cn)/activated T Nuclear Factor (NFAT) Pathway by 11R-VIVIT ;peptide Inhibits IL-6 and PGE2 Expression in Wear Particles Induced Osteoblast Cells

Effects of Local and Systemic Alendronate Delivery on Wear Debris-Induced Osteolysis in Vivo

In Vitro And In Vivo Evaluation Of The Osteogenic Ability Of Implant Surfaces With A Local Delivery Of Simvastatin

Stevioside Prevents Wear Particle-Induced Osteolysis by Inhibiting Osteoclastogenesis and Inflammatory Response via the Suppression of TAK1 Activation.

Inhibitory Effect of Zoledronic Acid on Osteolysls Induced by Human Periprosthetic Tissue:An Animal Study

Bone Responses to Simvastatin-Loaded Porous Implant Surfaces in an Ovariectomized Model.

Protection Against Titanium Particle-Induced Inflammatory Osteolysis by the Proteasome Inhibitor Bortezomib in Vivo

Mmp-9 Inhibition Suppresses Wear Debris-Induced Inflammatory Osteolysis Through Downregulation Of Rank/Rankl In A Murine Osteolysis Model

Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of RANKL/OPG

Effect of Simvastatin on Osteoprotegerin Expression in Bone Callus of Ovariectimized Rats

Vaccarin Prevents Titanium Particle‐induced Osteolysis and Inhibits RANKL‐induced Osteoclastogenesis by Blocking NF‐κB and MAPK Signaling Pathways

The Prevention of Titanium-Particle-induced Osteolysis by OA-14 Through the Suppression of the P38 Signaling Pathway and Inhibition of Osteoclastogenesis.

Smart Delivery of Biomolecules Interfering with Peri-Implant Repair in Osteoporotic Rats

Pharmacological Effects of a Recombinant Hpth(1-34) Derived Peptide on Ovariectomized Rats.

Strontium Ranelate Inhibits Titanium-Particle-Induced Osteolysis, by Restraining Inflammatory Osteoclastogenesis in Vivo